| Trial ID: | L0400 |
| Source ID: | NCT02408744
|
| Associated Drug: |
Pirfenidone
|
| Title: |
Utility of Prolonged-release Pirfenidone in the Progression of Chronic Kidney Disease
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Fibrosis|Chronic Kidney Disease
|
| Interventions: |
DRUG: Pirfenidone
|
| Outcome Measures: |
Primary: Evaluate the results of the use of Pirfenidone in the progression of renal damage in patients with Chronic Kidney Disease., The progression of renal damage in patients with Chronic Kidney Disease was evaluated according to stages 1-4 of classification KDIGO., three years | Secondary: Effect of the use of Pirfenidone in renal function, The renal function was monitored by cystatin C, reciprocal of serum creatinine and creatinine clearance collection of 24 hrs., Three years
|
| Sponsor/Collaborators: |
Sponsor: University of Guadalajara | Collaborators: Cell Therapy And Technology, S.a. De C.v.
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT
|
| Phases: |
PHASE1|PHASE2
|
| Enrollment: |
30
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2009-09
|
| Completion Date: |
2013-09
|
| Results First Posted: |
|
| Last Update Posted: |
2015-04-03
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT02408744
|
